Tags : Vischer

Banking & Finance

Vischer: Anokion raises $35 million financing

Anokion, a clinical-stage biotechnology company focused on treating autoimmune disease by restoring normal immune tolerance, recently closed an USD 35 million equity investment from Pfizer through the Pfizer Breakthrough Growth Initiative. Founded in Switzerland and based on innovation from the EPFL Life Sciences, Anokion is led by a diverse team of entrepreneurial scientists and experienced […]

Banking & Finance

Vischer advises Norgine Ventures in the financing of Lunaphore

Norgine Ventures has provided financing of approx. EUR 10 million to Lunaphore Technologies, a privately owned Swiss company spun out from EPFL. The financing was realised in form of private bonds with warrants which can be drawn down in multiple tranches. Based in Lausanne, Lunaphore Technologies has developed a game-changing chip technology which can extract […]

Deal & transactions

VISCHER advises Versantis on its sale to Gentif

Versantis, a private Swiss-based clinical stage biotechnology company focused on addressing the growing unmet medical needs in liver diseases, is to be sold to Genfit. With this acquisition, Genfit intends to expand its product portfolio with a Phase 2 ready programme based on first-in-class scanning liposome technology, a paediatric programme focused on urea cycle disorder […]

Capital Markets

VISCHER on the management buyout of Roventa-Henex

The management of Roventa-Henex has acquired 60% of the share capital of the company. The manufacturer of quality Swiss Made Private Label watches also designs, develops and distributes private label watches and related components. It was founded in 1959 by Norbert Schenkel in Biel. The Munich-based Findos Investor, an independent mid-market private equity fund, retains […]

Capital Markets

Advestra advised Keda Industrial Group and Ningbo Shanshan on their

As we have informed last 28th July, Keda Indus­tri­al Group and Ningbo Shan­shan were among the first com­pan­ies which suc­cess­fully lis­ted glob­al depos­it­ary receipts (GDRs) on SIX Swiss Exchange. Keda Indus­tri­al Group, whose A shares are lis­ted on the Shang­hai Stock Exchange, raised gross pro­ceeds in the amount of approx. USD 173 mio. from the offer­ing of GDRs and Ningbo Shan­shan, […]

Banking & Finance

VISCHER advises QoQa through a security token offering

QoQa Brew, a subsidiary of QoQa Services, has financed its craft brewery through a security token offering. The brewery will be located in the “QG”, a co-working eco-friendly space imagine by QoQa Services, a leading Swiss innovative daily sales website proposing attractive offers to its community. The new building designed by QoQa in Bussigny, the […]

Banking & Finance

VISCHER advises Mosanna Therapeutics on its Seed Financing Round

Mosanna Therapeutics, a Basel-based biotechnology company, has closed a Seed Financing Round led by Forty51 Ventures. The proceeds will be used for formulation and manufacturing optimization of the molecule MOS118 and for regulatory activities in preparation of the first Phase 1b clinical trial. Mosanna is developing the advanced small molecule MOS118, formerly know as AVE0118, […]